COMMUNIQUÉS West-GlobeNewswire

Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results

09/01/2019 - 15:05

SUNNYVALE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery, today announced [...]

Dr. Jeffrey D. Gross of Newport Beach, CA Now Offering Free Virtual Second Opinion Consultations for Surgery

09/01/2019 - 15:00

NEWPORT BEACH, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Dr. Jeffrey D. Gross, a board-certified neurological surgeon, today announced he is now offering comprehensive second opinion consultations for patients [...]

UPDATE -- Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.

09/01/2019 - 14:59

TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its [...]

Two Marrone Bio Innovations products, MBI-110 Biofungicide and Haven Sunprotectant, approved for sale in Canada

09/01/2019 - 14:31

DAVIS, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, today announced that two of its products have [...]

Sharps Compliance Announces Second Quarter Fiscal 2019 Conference Call and Webcast

09/01/2019 - 14:30

HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its second quarter 2019 results for the period ended December 31, 2018, before the opening of the [...]

Wildflower Experience Shop-in-Shop Retail Launches in New York City

09/01/2019 - 14:30

VANCOUVER, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), is excited to announce the opening of our first shop-in-shop partnership with Retail Worx [...]

Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media

09/01/2019 - 14:30

SEATTLE, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

OncBioMune Announces Former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer

09/01/2019 - 14:28

BATON ROUGE, La., Jan. 09, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.

09/01/2019 - 14:18

TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its [...]

Southeastern Grocers Partner with eTrueNorth to Launch CLIA-waived Laboratory for Point-of-Care Testing at Local Pharmacies

09/01/2019 - 14:00

BI-LO, Fresco y Más, Harveys Supermarket and Winn-Dixie pharmacies will accept eLabNetwork® vouchers and provide onsite wellness screenings FORT WORTH, Texas, Jan. 09, 2019 (GLOBE NEWSWIRE) -- e TrueNorth, the premier, [...]

Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office

09/01/2019 - 14:00

LAVAL, Québec, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium

09/01/2019 - 14:00

AlloSure utility studied in patients with delayed graft function BRISBANE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and [...]

Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient

09/01/2019 - 14:00

Buerger’s disease is a severe vascular inflammatory disease associated with high risk of amputation Patient was at a pre-amputation stage and was treated with PLX-PAD cell therapy under compassionate use treatment After [...]

Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

09/01/2019 - 14:00

Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer [...]

Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554

09/01/2019 - 14:00

Assignment of the “-fentrine” stem in the INN attests to RPL554’s dual phosphodiesterase inhibitor mechanism of action LONDON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma [...]

Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

09/01/2019 - 14:00

Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase II open-label trial in [...]

Akorn Receives FDA Warning Letter

09/01/2019 - 13:55

LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4, from the U.S. Food and [...]

Moleculin Announces Patient Recruitment Begins in Annamycin Clinical Trial In Poland

09/01/2019 - 13:30

Received European approval to ship Annamycin into Poland to start treating patients HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage [...]

Nephros Announces Preliminary Financial Results for Fiscal Year 2018

09/01/2019 - 13:30

Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company [...]